Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 11 | 2022 | 924 | 2.140 |
Why?
|
| Pollen | 5 | 2017 | 41 | 1.980 |
Why?
|
| Neutrophils | 6 | 2017 | 364 | 1.770 |
Why?
|
| Eosinophils | 11 | 2017 | 126 | 1.670 |
Why?
|
| Immunity, Innate | 6 | 2018 | 410 | 1.460 |
Why?
|
| Allergens | 7 | 2018 | 324 | 1.450 |
Why?
|
| Neutrophil Infiltration | 3 | 2017 | 65 | 1.430 |
Why?
|
| Antigens, Plant | 5 | 2017 | 40 | 1.280 |
Why?
|
| Rhinitis, Allergic, Seasonal | 4 | 2017 | 21 | 1.100 |
Why?
|
| DNA Damage | 7 | 2022 | 519 | 1.090 |
Why?
|
| Dander | 3 | 2018 | 7 | 1.040 |
Why?
|
| Cytokines | 10 | 2015 | 1339 | 1.030 |
Why?
|
| Oxidative Stress | 7 | 2022 | 803 | 0.980 |
Why?
|
| Receptors, Interleukin-8B | 4 | 2018 | 17 | 0.950 |
Why?
|
| DNA Glycosylases | 7 | 2023 | 33 | 0.930 |
Why?
|
| Respiratory Hypersensitivity | 2 | 2016 | 55 | 0.910 |
Why?
|
| DNA Repair | 5 | 2022 | 580 | 0.900 |
Why?
|
| Lung | 9 | 2021 | 1580 | 0.860 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2017 | 141 | 0.830 |
Why?
|
| Hypersensitivity | 3 | 2018 | 223 | 0.790 |
Why?
|
| Respiratory Mucosa | 4 | 2018 | 96 | 0.770 |
Why?
|
| Bronchoalveolar Lavage Fluid | 4 | 2017 | 154 | 0.710 |
Why?
|
| Airway Remodeling | 3 | 2018 | 23 | 0.680 |
Why?
|
| Interleukin-8 | 4 | 2017 | 205 | 0.670 |
Why?
|
| Epithelial-Mesenchymal Transition | 4 | 2018 | 258 | 0.610 |
Why?
|
| Lymphocyte Antigen 96 | 2 | 2016 | 5 | 0.600 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2018 | 8 | 0.580 |
Why?
|
| Cytosine | 1 | 2018 | 58 | 0.570 |
Why?
|
| Pneumonia | 3 | 2018 | 342 | 0.560 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 217 | 0.560 |
Why?
|
| Phenylurea Compounds | 1 | 2018 | 58 | 0.560 |
Why?
|
| Plant Extracts | 3 | 2016 | 137 | 0.550 |
Why?
|
| Cats | 5 | 2018 | 119 | 0.540 |
Why?
|
| Bronchi | 3 | 2017 | 101 | 0.530 |
Why?
|
| Blood-Air Barrier | 1 | 2017 | 5 | 0.520 |
Why?
|
| Ambrosia | 1 | 2017 | 15 | 0.520 |
Why?
|
| Reactive Oxygen Species | 7 | 2022 | 517 | 0.510 |
Why?
|
| Betacoronavirus | 1 | 2020 | 285 | 0.510 |
Why?
|
| Peptide Hydrolases | 1 | 2017 | 131 | 0.480 |
Why?
|
| Guanine | 5 | 2022 | 65 | 0.450 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 364 | 0.450 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2015 | 12 | 0.450 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 375 | 0.450 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 177 | 0.430 |
Why?
|
| Leukotriene Antagonists | 1 | 2014 | 16 | 0.430 |
Why?
|
| Th2 Cells | 1 | 2015 | 185 | 0.420 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2017 | 301 | 0.410 |
Why?
|
| Acetates | 1 | 2014 | 79 | 0.410 |
Why?
|
| Quinolines | 1 | 2014 | 119 | 0.390 |
Why?
|
| Mice, Knockout | 6 | 2018 | 3831 | 0.390 |
Why?
|
| Pandemics | 1 | 2020 | 1158 | 0.380 |
Why?
|
| Angiolymphoid Hyperplasia with Eosinophilia | 1 | 2012 | 4 | 0.370 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2012 | 30 | 0.370 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2012 | 38 | 0.370 |
Why?
|
| NF-kappa B | 3 | 2021 | 449 | 0.350 |
Why?
|
| Influenza A virus | 1 | 2012 | 143 | 0.350 |
Why?
|
| Hypereosinophilic Syndrome | 1 | 2011 | 9 | 0.350 |
Why?
|
| Animals | 18 | 2023 | 33891 | 0.340 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 357 | 0.330 |
Why?
|
| Immune System Phenomena | 1 | 2010 | 2 | 0.330 |
Why?
|
| Ciliary Motility Disorders | 1 | 2010 | 13 | 0.330 |
Why?
|
| Hematoma, Epidural, Spinal | 1 | 2010 | 7 | 0.330 |
Why?
|
| Foramen Ovale | 1 | 2010 | 4 | 0.320 |
Why?
|
| Cerebral Palsy | 1 | 2011 | 86 | 0.310 |
Why?
|
| Bifidobacterium | 1 | 2010 | 66 | 0.310 |
Why?
|
| Inflammation | 6 | 2022 | 1490 | 0.310 |
Why?
|
| Respiratory Sounds | 1 | 2009 | 80 | 0.300 |
Why?
|
| Humans | 38 | 2023 | 130776 | 0.290 |
Why?
|
| Trichosporon | 1 | 2008 | 5 | 0.290 |
Why?
|
| Bacteria | 1 | 2013 | 538 | 0.290 |
Why?
|
| DNA | 4 | 2022 | 1413 | 0.290 |
Why?
|
| Fungemia | 1 | 2008 | 21 | 0.290 |
Why?
|
| Aortic Coarctation | 1 | 2010 | 98 | 0.290 |
Why?
|
| Mycoses | 1 | 2008 | 112 | 0.270 |
Why?
|
| Probiotics | 1 | 2010 | 226 | 0.260 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2010 | 276 | 0.250 |
Why?
|
| Influenza, Human | 1 | 2012 | 701 | 0.240 |
Why?
|
| Immunoglobulin E | 4 | 2018 | 206 | 0.240 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2009 | 385 | 0.230 |
Why?
|
| Procaterol | 2 | 2017 | 2 | 0.220 |
Why?
|
| Superoxides | 4 | 2013 | 129 | 0.210 |
Why?
|
| Mice | 11 | 2022 | 18208 | 0.210 |
Why?
|
| Intellectual Disability | 1 | 2011 | 1077 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 4695 | 0.210 |
Why?
|
| Cells, Cultured | 6 | 2015 | 2905 | 0.190 |
Why?
|
| Epithelial Cells | 3 | 2017 | 899 | 0.190 |
Why?
|
| Male | 15 | 2021 | 64680 | 0.180 |
Why?
|
| Eosinophil-Derived Neurotoxin | 2 | 2013 | 2 | 0.180 |
Why?
|
| Kartagener Syndrome | 1 | 2021 | 13 | 0.180 |
Why?
|
| Otitis Media | 1 | 2021 | 89 | 0.170 |
Why?
|
| Allergists | 1 | 2020 | 10 | 0.170 |
Why?
|
| Basophils | 3 | 2009 | 14 | 0.160 |
Why?
|
| Biomarkers | 5 | 2018 | 3400 | 0.160 |
Why?
|
| Pyrophosphatases | 3 | 2009 | 22 | 0.160 |
Why?
|
| Quarantine | 1 | 2020 | 18 | 0.160 |
Why?
|
| Phosphoric Diester Hydrolases | 3 | 2009 | 68 | 0.160 |
Why?
|
| Drug Repositioning | 1 | 2020 | 32 | 0.160 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 48 | 0.160 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 57 | 0.160 |
Why?
|
| Masks | 1 | 2020 | 38 | 0.160 |
Why?
|
| Receptors, Virus | 1 | 2020 | 96 | 0.160 |
Why?
|
| Alanine | 1 | 2020 | 161 | 0.150 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 145 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2010 | 3869 | 0.150 |
Why?
|
| Cryptomeria | 2 | 2009 | 2 | 0.150 |
Why?
|
| Staphylococcus aureus | 2 | 2013 | 481 | 0.150 |
Why?
|
| Chromatography, Gas | 1 | 2018 | 22 | 0.150 |
Why?
|
| Cell Line | 4 | 2017 | 2569 | 0.140 |
Why?
|
| Genome | 2 | 2023 | 467 | 0.140 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2018 | 97 | 0.140 |
Why?
|
| Glutathione Disulfide | 1 | 2017 | 20 | 0.130 |
Why?
|
| Deoxyguanosine | 1 | 2017 | 12 | 0.130 |
Why?
|
| Rhinitis, Allergic | 1 | 2017 | 18 | 0.130 |
Why?
|
| Receptor, PAR-2 | 1 | 2017 | 4 | 0.130 |
Why?
|
| Coculture Techniques | 2 | 2014 | 232 | 0.130 |
Why?
|
| Nasal Mucosa | 1 | 2017 | 83 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 4664 | 0.120 |
Why?
|
| Antiviral Agents | 2 | 2020 | 811 | 0.120 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2014 | 146 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 288 | 0.120 |
Why?
|
| Neutrophil Activation | 1 | 2016 | 12 | 0.120 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 2341 | 0.120 |
Why?
|
| Anti-Allergic Agents | 1 | 2016 | 29 | 0.120 |
Why?
|
| Mucins | 1 | 2015 | 69 | 0.120 |
Why?
|
| Alternaria | 1 | 2015 | 4 | 0.120 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 1131 | 0.110 |
Why?
|
| Interleukin-5 | 1 | 2015 | 51 | 0.110 |
Why?
|
| Interleukin-17 | 1 | 2016 | 129 | 0.110 |
Why?
|
| Interleukin-18 | 1 | 2015 | 76 | 0.110 |
Why?
|
| HEK293 Cells | 1 | 2017 | 809 | 0.110 |
Why?
|
| Leukotrienes | 1 | 2014 | 7 | 0.110 |
Why?
|
| Female | 13 | 2021 | 70630 | 0.110 |
Why?
|
| Sulfides | 1 | 2014 | 22 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 698 | 0.100 |
Why?
|
| Vimentin | 1 | 2014 | 60 | 0.100 |
Why?
|
| Smad3 Protein | 1 | 2014 | 54 | 0.100 |
Why?
|
| Cyclopropanes | 1 | 2014 | 73 | 0.100 |
Why?
|
| Collagen Type I | 1 | 2014 | 112 | 0.100 |
Why?
|
| Adult | 5 | 2017 | 31269 | 0.100 |
Why?
|
| Age Factors | 1 | 2020 | 2849 | 0.100 |
Why?
|
| Cysteine | 1 | 2014 | 137 | 0.100 |
Why?
|
| Regression Analysis | 1 | 2015 | 768 | 0.100 |
Why?
|
| Prevotella | 1 | 2013 | 10 | 0.100 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2014 | 73 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 301 | 0.100 |
Why?
|
| Prevalence | 1 | 2020 | 2684 | 0.100 |
Why?
|
| Cytoskeleton | 1 | 2014 | 167 | 0.100 |
Why?
|
| Haemophilus influenzae | 1 | 2013 | 135 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 4 | 2015 | 975 | 0.090 |
Why?
|
| Calcitriol | 1 | 2012 | 63 | 0.090 |
Why?
|
| Actins | 1 | 2014 | 314 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 3062 | 0.090 |
Why?
|
| Autophagy | 1 | 2015 | 422 | 0.090 |
Why?
|
| Receptors, CXCR4 | 1 | 2012 | 71 | 0.090 |
Why?
|
| Vitamins | 1 | 2012 | 114 | 0.090 |
Why?
|
| Dermatitis, Atopic | 1 | 2012 | 53 | 0.090 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2011 | 11 | 0.090 |
Why?
|
| Budesonide | 1 | 2011 | 18 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 1843 | 0.090 |
Why?
|
| Prednisolone | 1 | 2011 | 70 | 0.090 |
Why?
|
| Cell Count | 1 | 2011 | 213 | 0.080 |
Why?
|
| Cyclosporine | 1 | 2011 | 131 | 0.080 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2010 | 22 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2010 | 5230 | 0.080 |
Why?
|
| Egtazic Acid | 1 | 2010 | 18 | 0.080 |
Why?
|
| Pertussis Toxin | 1 | 2010 | 18 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2014 | 1568 | 0.080 |
Why?
|
| Laminectomy | 1 | 2010 | 24 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1382 | 0.080 |
Why?
|
| Cell Degranulation | 1 | 2010 | 28 | 0.080 |
Why?
|
| Ventricular Septum | 1 | 2010 | 17 | 0.080 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 70 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 3700 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2015 | 2558 | 0.080 |
Why?
|
| Urinary Bladder | 1 | 2011 | 220 | 0.080 |
Why?
|
| Bone Marrow | 1 | 2011 | 314 | 0.080 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2010 | 84 | 0.080 |
Why?
|
| Wheat Hypersensitivity | 1 | 2009 | 4 | 0.070 |
Why?
|
| Phagocytosis | 1 | 2010 | 189 | 0.070 |
Why?
|
| Radiography | 1 | 2011 | 739 | 0.070 |
Why?
|
| Gastrointestinal Tract | 1 | 2011 | 224 | 0.070 |
Why?
|
| Voriconazole | 1 | 2008 | 29 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2018 | 2440 | 0.070 |
Why?
|
| Drainage | 1 | 2010 | 249 | 0.070 |
Why?
|
| Surveys and Questionnaires | 2 | 2009 | 4039 | 0.070 |
Why?
|
| DNA, Fungal | 1 | 2008 | 77 | 0.070 |
Why?
|
| Pancreatic Elastase | 1 | 2008 | 12 | 0.070 |
Why?
|
| Adolescent | 4 | 2011 | 20832 | 0.070 |
Why?
|
| Cathepsins | 1 | 2008 | 26 | 0.070 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2008 | 58 | 0.070 |
Why?
|
| Child | 4 | 2012 | 26214 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3418 | 0.070 |
Why?
|
| Triazoles | 1 | 2008 | 143 | 0.070 |
Why?
|
| Infant | 3 | 2021 | 13323 | 0.070 |
Why?
|
| Desensitization, Immunologic | 1 | 2009 | 104 | 0.070 |
Why?
|
| Transcriptome | 1 | 2015 | 1130 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 642 | 0.070 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2008 | 133 | 0.070 |
Why?
|
| Serine Endopeptidases | 1 | 2008 | 197 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2010 | 8567 | 0.060 |
Why?
|
| Antifungal Agents | 1 | 2008 | 296 | 0.060 |
Why?
|
| Recurrence | 1 | 2009 | 1478 | 0.060 |
Why?
|
| Time Factors | 1 | 2016 | 6241 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 1457 | 0.060 |
Why?
|
| Pyrimidines | 1 | 2008 | 450 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 1236 | 0.060 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2023 | 13 | 0.050 |
Why?
|
| Echocardiography | 1 | 2010 | 1139 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2015 | 586 | 0.050 |
Why?
|
| Cell Movement | 2 | 2021 | 871 | 0.050 |
Why?
|
| Cricetinae | 1 | 2023 | 363 | 0.050 |
Why?
|
| RNA Interference | 2 | 2014 | 491 | 0.050 |
Why?
|
| Helicobacter Infections | 1 | 2011 | 1302 | 0.040 |
Why?
|
| Japan | 1 | 2021 | 166 | 0.040 |
Why?
|
| Young Adult | 1 | 2015 | 10021 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2010 | 3716 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2021 | 4670 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2010 | 15011 | 0.040 |
Why?
|
| Prognosis | 1 | 2008 | 4934 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2021 | 467 | 0.040 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2017 | 51 | 0.030 |
Why?
|
| Middle Aged | 1 | 2017 | 28499 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2009 | 790 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2015 | 26 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2015 | 53 | 0.030 |
Why?
|
| Caspase 1 | 1 | 2015 | 49 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2015 | 89 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 134 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2015 | 129 | 0.030 |
Why?
|
| Body Fluids | 1 | 2014 | 45 | 0.030 |
Why?
|
| Stress Fibers | 1 | 2014 | 4 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 432 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 151 | 0.030 |
Why?
|
| Respiratory System | 1 | 2014 | 96 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 193 | 0.030 |
Why?
|
| Telomere | 1 | 2015 | 219 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2015 | 246 | 0.030 |
Why?
|
| Environmental Pollutants | 1 | 2014 | 81 | 0.030 |
Why?
|
| Inflammasomes | 1 | 2015 | 153 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 303 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 160 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 1623 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2014 | 331 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1218 | 0.020 |
Why?
|
| Cell Communication | 1 | 2013 | 186 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 661 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 304 | 0.020 |
Why?
|
| Aminoquinolines | 1 | 2011 | 36 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 419 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2011 | 34 | 0.020 |
Why?
|
| Homeostasis | 1 | 2015 | 712 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2014 | 403 | 0.020 |
Why?
|
| Heart Murmurs | 1 | 2010 | 13 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2011 | 278 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 1232 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 916 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 829 | 0.020 |
Why?
|
| Cysts | 1 | 2010 | 89 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2010 | 166 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2009 | 37 | 0.020 |
Why?
|
| Gliadin | 1 | 2009 | 4 | 0.020 |
Why?
|
| Cathepsin G | 1 | 2008 | 3 | 0.020 |
Why?
|
| Plant Proteins | 1 | 2009 | 85 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2009 | 321 | 0.020 |
Why?
|
| Chemokines | 1 | 2008 | 124 | 0.020 |
Why?
|
| Aging | 1 | 2015 | 1252 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 615 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 1311 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 2126 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 2307 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 17674 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2008 | 755 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12910 | 0.010 |
Why?
|
| Quality of Life | 1 | 2008 | 2089 | 0.010 |
Why?
|